Xuezhu Rong
First Hospital of China Medical University(CN)China Medical University(CN)
Publications by Year
Research Areas
Hippo pathway signaling and YAP/TAZ, Wnt/β-catenin signaling in development and cancer, Cancer-related gene regulation, RNA modifications and cancer, Epigenetics and DNA Methylation
Most-Cited Works
- → WWC3 regulates the Wnt and Hippo pathways via Dishevelled proteins and large tumour suppressor 1, to suppress lung cancer invasion and metastasis(2017)81 cited
- → Cytosolic TMEM88 Promotes Invasion and Metastasis in Lung Cancer Cells by Binding DVLS(2015)78 cited
- → A novel long non-coding RNA LINC00355 promotes proliferation of lung adenocarcinoma cells by down-regulating miR-195 and up-regulating the expression of CCNE1(2019)41 cited
- → Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance Induced by Membranous/Cytoplasmic/Nuclear Translocation of Epidermal Growth Factor Receptor(2019)40 cited
- → The coiled-coil domain of oncogene RASSF 7 inhibits hippo signaling and promotes non-small cell lung cancer(2017)38 cited
- → CCDC85B promotes non‐small cell lung cancer cell proliferation and invasion(2018)30 cited
- → WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling(2018)27 cited
- → WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression(2021)25 cited
- → PLEKHH2 binds β-arrestin1 through its FERM domain, activates FAK/PI3K/AKT phosphorylation, and promotes the malignant phenotype of non-small cell lung cancer(2022)22 cited
- → KCTD11 inhibits progression of lung cancer by binding to β‐catenin to regulate the activity of the Wnt and Hippo pathways(2021)20 cited